Estrogen Effects on Bone in the Male Skeleton

Principles of Bone Biology: Volume 1-2, Third Edition

Volumn , Issue , 2008, Pages 1801-1818

  Gennari, Luigi ^a   Khosla, Sundeep ^a   Bilezikian, John P ^b  

^a MAYO CLINIC   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 69949087795     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373884-4.00022-7     Document Type: Chapter

References (137)

1. S. Amin, Y. Zhang, C.T. Sawin, et al. (2000) Association of hypogonadism and estradiol levels with bone mineral density in elderly men from the Framingham study. Ann. Intern. Med. 133 951-963.
2. F.H. Anderson, R.M. Francis, R.T. Peaston and H.J. Wastell (1997) Androgen supplementation in eugonadal men with osteoporosis: Effects of six months’ treatment on markers of bone formation and resorption. J. Bone Miner. Res. 12 472-478.
3. E. Barrett-Connor, J.E. Mueller, D.G. von Muhlen, G.A. Laughlin, D.L. Schneider and D.J. Sartoris (2000) Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 85 219-223.
4. T.J. Beck, C.B. Ruff, W.W. Scott Jr., C.C. Plato, J.D. Tobin and C.A. Quan (1992) Sex differences in geometry of the femoral neck with aging: A structural analysis of bone mineral data. Calcif. Tissue Int. 50 24-29.
5. S. Bertelloni, G.I. Baroncelli, M. Ferdeghini, G. Perri and G. Saggese (1998) Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty. J. Clin. Endocrinol. Metab. 83 4280-4283.
6. J.P. Bilezikian (1999) Osteoporosis in men. J. Clin. Endocrinol. Metab. 84 3134-3431.
7. J.P. Bilezikian, A. Morishima, J. Bell and M.M. Grumbach (1998) Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N. Engl. J. Med. 339 599-603.
8. J.P. Bilezikian (2002) Sex steroids, mice, and men: When androgens and estrogens get very close to each other. J. Bone Miner. Res. 17 563-566.
9. A. Bjornerem, N. Emaus, G.K.R. Berntsen, R.M. Joakimsen, V. Fonnebo, T. Wilsgaard, P. Oian, E. Seeman and B. Straume (2007) Circulating sex steroids, sex hormone binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausal women and men: the Tromso study. Calcif. Tissue Int. 81 65-72.
10. R. Boullion, M. Bex, D. Vanderschueren and S. Boonen (2004) Estrogen are essential for male pubertal periosteal expansion. J. Clin. Endocrinol. Metab. 89 6025-6029.
11. S.E. Bulun, I.M. Rosenthal, A.M.H. Brodie, S.E. Inskter, W.P. Zeller, A.M. DiGeorge, S.D. Frasier, M.W. Kilgore and E.R. Simpson (1993) Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. J. Clin. Endocrinol. Metab. 77 1616-1621.
12. S.E. Bulun, L.S. Noble, K. Takayama, et al. (1999) Endocrine disorders associated with inappropriately high aromatase expression. J. Steroid Biochem. Mol. Biol. 61 133-139.
13. C. Carani, K. Qin, M. Simoni, S. Faustini-Fustini Serpente, J. Boyd, K.S. Korach and E.R. Simpson (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337 91-95.
14. M. Caruso-Nicoletti, F. Cassarola, M. Skerda, J.L. Ross, D.L. Loriaux and G.B. Cutler Jr. (1985) Short-term, low-dose estradiol accelerates ulnar growth in boys. J. Clin. Endocrinol. Metab. 61 896-898.
15. J.R. Center, T.V. Nguyen, D. Schneider, P.N. Sambrook and J.A. Eisman (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353 878-882.
16. J.R. Center, T.V. Nguyen, P.N. Sambrook and J.A. Eisman (1999) Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J. Clin. Endocrinol. Metab. 84 3626-3635.
17. A.S. Chagin, M.K. Lindberg, N. Andersson, et al. (2004) Estrogen receptor-beta inhibits skeletal growth and has the capacity to mediate growth plate fusion in female mice. J. Bone Miner. Res. 19 72-77.
18. P. Coen, H. Kulin, T. Ballantine, et al. (1991) An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. N. Engl. J. Med. 324 317-322.
19. C. Cooper, G. Campion and L.J. Melton (1992) Hip fractures in the elderly: A worldwide projection. Osteoporos. Int. 2 285-289.
20. J.F. Couse, S.W. Curtis, T.F. Washburn, et al. (1995) Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 9 1441-1454.
21. J.F. Couse and K.S. Korach (1999) Estrogen receptor null mice: What have we learned and where will they lead us? Endoc. Rev. 20 359-417.
22. S.R. Cummings and L.J. Melton III. (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359 1761-1767.
23. J. Deladoey, C. Fluck, M. Bex, N. Yoshimur, N. Harada and P.E. Mullis (1999) Aromatase deficiency caused by a novel P450 arom gene mutation: Impact of absent estrogen production on serum gonadotropin concentration in a boy. J. Clin. Endocrinol. Metab. 84 4050-4054.
24. P.D. Delmas, N.H. Bjarnason, B.H. Mitlak, et al. (1997) Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N. Engl. J. Med. 337 1641-1647.
25. P.M. Doran, B.L. Riggs, E.J. Atkinson and S. Khosla (2001) Effects of raloxifene, a selective estrogen receptor modulator, on bone turnover markers and serum sex steroid and lipid levels in elderly men. J. Bone Miner. Res. 16 2118-2125.
26. Y. Duan, A.M. Parfitt and E. Seeman (1999) Vertebral bone mass, size, and volumetric density in women with spinal fractures. J. Bone Miner. Res. 14 1796-1802.
27. E.J. Duschek, L.J. Gooren and C. Netelenbos (2004) Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men. Eur. J. Endocrinol. 150 539-546.
28. K.E. Ensrud, C.E. Lewis, L.C. Lambert, B.C. Taylor, H.A. Fink, E. Barrett-Connor, J.A. Cauley, M.L. Stefanick and E. Orwoll (2006) Endogenous sex steroids, weight change and rates of hip bone loss in older men: The MrOS study. Osteoporos. Int. 17 1329-1336.
29. A. Falahati-Nini, B.L. Riggs, E.J. Atkinson, W.M. O’ Fallon, R. Eastell and S. Khosla (2000) Relative contributions of testosterone versus estrogen in regulating bone resorption and formation in normal elderly men. J. Clin. Invest. 106 1553-1560.
30. H.A. Fink, S.K. Ewing, K.E. Ensrud, E. Barrett-Connor, B.C. Taylor, J.A. Cauley and E.S. Orwoll (2006) Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J. Clin. Endocrinol. Metab. 91 3908-3915.
31. J.S. Finkelstein, R.M. Neer, B.M.K. Biller, J.D. Crawford and A. Klibanski (1992) Osteopenia in adult men with histories of delayed puberty. N. Engl. J. Med. 326 600-604.
32. J.S. Finkelstein, A. Klibanski and R.M. Neer (1996) A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J. Clin. Endocrinol. Metab. 81 1152-1155.
33. C.R. Fisher, K.H. Graves, A.F. Parlow and E.R. Simpson (1998) Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. USA. 95 6965-6970.
34. H.K. Genant, C. Cooper, G. Poor, I. Reid, G. Ehrlich, J. Kanis, et al. (1999) Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos. Int. 10 259-264.
35. L. Gennari, D. Merlotti, G. Martini, et al. (2003) Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J. Clin. Endocrinol. Metab. 88 5327-5333.
36. L. Gennari, R. Nuti and J.P. Bilezikian (2004) Aromatase activity and bone homeostasis in men. J. Clin. Endocrinol. Metab. 89 5898-5907.
37. L. Gennari, L. Masi, D. Merlotti, et al. (2004) A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism. J. Clin. Endocrinol. Metab. 89 2803-2810.
38. L. Gennari and J.P. Bilezikian (2007) Osteoporosis in men. Endocrinol. Metab. Clin. North. Am. 36 399-419.
39. M.A. Gentile, H. Zhang, S. Harada, G.A. Rodan and D.B. Kimmel (2001) Bone response to estrogen replacement in OVX double estrogen receptor (α and β) knockout mice. J. Bone Miner. Res. 16 S146.
40. V. Gilsanz, M.I. Beochar, T. Roe, M.L. Loro, J.W. Sayre and W.G. Goodman (1994) Gender differences in vertebral body sizes in children and adolescents. Radiology 190 673-677.
41. E.P. Giorgi and T.F. Moses (1975) Dissociation of testosterone from plasma protein during superfusion of slices from human prostate. J. Endocrinol. 65 279-280.
42. G.A. Greendale, S. Edelstein and E. Barrett-Connor (1997) Endogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study. J. Bone Miner. Res. 12 1833-1843.
43. M.M. Grumbach and R.J. Auchus (1999) Estrogen: Consequences and implications of human mutations in synthesis and action. J. Clin. Endocrinol. Metab. 84 4677-4694.
44. M.M. Grumbach and D.M. Styne (1998) Puberty: Ontogeny, neuroendocrinology, physiology, and disorders. J.D. Wilson, D.W. Foster, H.M. Kronenberg, P.R. Larsen (Eds) Williams Textbook of Endocrinology 9th Ed Philadelphia: Saunders 1509-1625.
45. S.M. Harman, J.F. Metter, J.D. Tobin, J. Pearson and M.R. Blackman (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J. Clin. Endocrinol. Metab. 86 724-731.
46. H.H. Harris, J.A. Katzenellenbogen and B.S. Katzenellenbogen (2002) Characterization of the biological roles of the estrogen receptor, ERα and ERβ, in estrogen target tissues in vivo through the use of an ERα-selective ligand. Endocrinology 143 4172-4177.
47. D.L. Hemsell, C.D. Edman, J.F. Marks, P.K. Siiteri and P.C. MacDonald (1977) Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy. J. Clin. Invest. 60 455-464.
48. B.L. Hermann, B. Saller, O.E. Janssen, et al. (2002) Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J. Clin. Endocrinol. Metab. 87 5476-5484.
49. M.H. Herve, M.L. Kottler and M. Pura (2004) Human gene mutations. Gene symbol: CYP19 Disease: Aromatase deficiency. Hum. Genet. 114 224.
50. S. Honda, N. Harada, S. Ito, Y. Takagi and S. Maeda (1998) Disruption of sexual behaviour in male aromatase-deficient mice lacking exons 1 and 2 of the cyp 19 gene. Biochem. Biophys. Res. Commun. 252 445-449.
51. H.L. Jessop, R.F. Suswillo, S.C. Rawlinson, et al. (2004) Osteoblast-like cells from estrogen receptor alpha knockout mice have deficient responses to mechanical strain. J. Bone Miner. Res. 19 938-946.
52. R.P. Kelch, M.R. Jenner, R. Weinstein, S.L. Kaplan and M.M. Grumbach (1972) Estradiol and testosterone secretion by human, simian, and canine testes, in males with hypogonadism and in male pseudohermaphrodites with the feminizing testes syndrome. J. Clin. Invest. 51 824-830.
53. S. Khosla, L.J. Melton III., E.J. Atkinson, W.M. O’ Fallon, G.G. Klee and B.L. Riggs (1998) Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J. Clin. Endocrinol. Metab. 83 2266-2274.
54. S. Khosla, L.J. Melton III., E.J. Atkinson and W.M. O'Fallon (2001) Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J. Clin. Endocrinol. Metab. 86 3555-3561.
55. S. Khosla, L.J. Melton III. and B.L. Riggs (2002) Clinical review 144: Estrogen and the male skeleton. J. Clin. Endocrinol. Metab. 87(4), 1443-1450.
56. S. Khosla, L.J. Melton III., R.A. Robb, et al. (2005) Relationship of volumetric BMD and structural parameters at different skeletal sites to sex steroid levels in men. J. Bone Miner. Res. 20 730-740.
57. S. Khosla, B.L. Riggs, R.A. Robb, et al. (2005) Relationship of volumetric bone density and structural parameters at different skeletal sites to sex steroid levels in women. J. Clin. Endocrinol. Metab. 90 5096-5103.
58. S. Khosla, B.L. Riggs, E.J. Atkinson, A.L. Oberg, L.J. McDaniel, M. Holets, J.M. Peterson and L.J. Melton III. (2006) Effects of sex and age on bone microstructure at the ultradistal radius: a population–based noninvasive in vivo assessment. J. Bone Miner. Res. 21 124-131.
59. S. Khosla, L.J. Melton III., S.J. Achenbach, A.L. Oberg and B.L. Riggs (2006) Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men. J. Clin. Endocrinol. Metab. 91 885-891.
60. B.T. Kim, L. Mosekilde, Y. Duan, X.Z. Zhang, L. Tornvig, J.S. Thomsen and E. Seeman (2003) The structural and hormonal basis of sex differences in peak appendicular bone strength in rats. J. Bone Miner. Res. 18 150-155.
61. I.Y. Kim, D.H. Seong, B.C. Kim, et al. (2002) Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Cancer Res. 62 3649-3653.
62. J.M. Kindblom, M. Lorentzon, E. Norjavaara, A. Hellqvist, S. Nilsson, D. Mellström and C. Ohlsson (2006) Pubertal timing predicts previous fractures and BMD in young adult men: the GOOD study. J. Bone Miner. Res. 21 790-795.
63. K.S. Korach, J.F. Couse, S.W. Curtis, T.F. Washburn, J. Lindzey, K.S. Kimbro, E.M. Eddy, S. Migliaccio, S.M. Snedeker, D.B. Lubahn, D.W. Schomberg and E.P. Smith (1996) Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes. Recent Prog Horm. Res. 51 159-186.
64. J.H. Krege, J.B. Hodgin, J.F. Couse, et al. (1998) Generation and reproductive phenotype of mice lacking estrogen receptor β. Proc. Natl. Acad. Sci. USA. 95 15677-15682.
65. F. Labrie, A. Belanger, L. Cusan and B. Candas (1997) Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab. 82 2403-2409.
66. B.Z. Leder, K.M. LeBlanc, D.A. Schoenfeld, R. Eastell and J.S. Finkelstein (2003) Differential effects of androgens and estrogens on bone turnover in normal men. J. Clin. Endocrinol. Metab. 88 204-210.
67. J.B. Lian, G.S. Stein, E. Canalis, P. Gehron Robey and A.L. Boskey (1999) Bone formation: Osteoblast lineage cells, growth factors, matrix proteins, and the mineralization process. M.F. Favus (Eds) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 4th Ed. Philadelphia: Lippincott Williams & Wilkins 14-38.
68. M.K. Lindberg, S. Moverare, S. Skrtic, S. Alatalo, J. Halleen, S. Mohan, J.A. Gustafsson and C. Ohlsson (2002) Two different pathways for the maintenance of trabecular bone in adult male mice. J. Bone Miner. Res. 17 555-562.
69. P.Y. Liu, J. Beilin, C. Meier, T.V. Nguyen, J.R. Center, P.J. Leedman, M.J. Seibel, J.A. Eisman and D.J. Handelsman (2007) Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts. J. Clin. Endocrinol. Metab. 92 3599-3603.
70. A.C. Looker, E.S. Orwoll, C.C. Johnston Jr., et al. (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J. Bone Miner. Res. 12 1761-1768.
71. M. Lorentzon, C. Swanson, N. Andersson, D. Mellstrom and C. Ohlsson (2005) Free testosterone is a positive, whreas free estradiol is a negative predictor of cortical bone size in young Swedisch men: the GOOD study. J. Bone Miner. Res. 20 1334-1341.
72. D.B. Lubahn, J.S. Moyer, T.S. Golding, J.F. Couse, K.S. Korach and O. Smithies (1993) Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA 90 11162-11166.
73. L. Maffei, Y. Murata, V. Rochira, et al. (2004) Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate and estradiol treatment. J. Clin. Endocrinol. Metab. 89 61-70.
74. L. Maffei, V. Rochira, L. Zirilli, P. Antunez, C. Aranda, B. Fabre, M.L. Simone, E. Pignatti, E.R. Simpson, S. Houssami, C.D. Clyne and C. Carani (2007) A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin. Endocrinol. 67 218-224.
75. A. Manni, W.M. Pardridge, W. Cefalu, B.C. Nisula, C.W. Bardin, S.J. Santner and R.J. Santen (1985) Bioavailability of albumin-bound testosterone. J. Clin. Endocrinol. Metab. 61 705-710.
76. S.C. Manolagas (2000) Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21 115-137.
77. R.M. Martin, C.J. Lin, M. Nishi, et al. (2003) Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. J. Clin. Endocrinol. Metab. 88 3027-3034.
78. C. Matsumoto, M. Inada, K. Toda and C. Miyaura (2006) Estrogen and androgen play distinct roles in bone turnover in male mice before and after reaching sexual maturity. Bone 38 220-226.
79. D. Mellström, O. Johnell, O. Ljunggren, A.L. Eriksson, M. Lorentzon, H. Mallmin, A. Holmberg, I. Redlund-Johnell, E. Orwoll and C. Ohlsson (2006) Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J. Bone Miner. Res. 21 529-535.
80. L.K. McCauley, T.F. Tozum, K.M. Kozloff, et al. (2003) Transgenic models of metabolic bone disease: impact of estrogen receptor deficiency on skeletal metabolism. Connect. Tissue Res. 44 250-263.
81. K.E. McDougall, M.J. Perry, R.L. Gibson, et al. (2002) Estrogen-induced osteogenesis in intact female mice lacking ERbeta. Am. J. Physiol. 283 E817-eE823.
82. A. Morishima, M.M. Grumbach, E.R. Simpson, C. Fisher and K. Qin (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80 3689-3698.
83. C. Miyaura, K. Toda, M. Inada, et al. (2001) Sex- and age-related response to aromatase deficiency in bone. Biochem. Biophys. Res. Commun. 280 1062-1068.
84. T. Nakamura, Y. Imai, T. Matsumoto, S. Sato, K. Takeuchi, K. Igarashi, Y. Harada, Y. Azuma, A. Krust, Y. Yamamoto, H. Nishina, S. Takeda, H. Takayanagi, D. Metzger, J. Kanno, K. Takaoka, T.J. Martin, P. Chambon and S. Kato (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of fas ligand in osteoclasts. Cell. 130 811-823.
85. B. Ongphiphadhanakul, R. Rajatanavin, S. Chanprasertyothin, N. Piaseu and L. Chailurkit (1998) Serum oestradiol and oestrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin. Endocrinol. (Oxford). 49 803-809.
86. E.S. Orwoll (1995) Osteoporosis in men. Endocr. Rev. 16 87-116.
87. E. Orwoll (1995) Gender differences in the skeleton: Osteoporosis. J. Women's Health 4 429-431.
88. E.S. Orwoll (1998) Osteoporosis in men. Endocrinol. Metab. Clin. North Am. 27 349-368.
89. E. Orwoll, L.C. Lambert, L.M. Marshall, K. Phipps, J. Blank, E. Barret-Connor, et al. (2006) Testosterone and estradiol among older men. J. Clin. Endocrinol. Metab. 91 1336-1344.
90. O.K. Oz, J.E. Zerwekh, C. Risher, K. Graes, L. Nanu, R. Millsaps and E.R. Simpson (2000) Bone has a sexually dimorphic response to aromatase deficiency. J. Bone Miner. Res. 15 507-514.
91. O.K. Oz, G. Hirasawa, J. Lawson, et al. (2001) Bone phenotype of the aromatase deficient mouse. J. Steroid. Biochem. Mol. Biol. 79 49-59.
92. V. Parikka, Z. Peng, T. Hentunen, et al. (2005) Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice. Eur. J. Endocrinol. 152 301-314.
93. Z.Q. Peng, X.D. Li, S. Makela, H.K. Vaananen and M. Poutanen (2004) Skeletal changes in transgenic male mice expressing human cytochrome P450 aromatase. J. Bone Miner. Res. 19 1320-1328.
94. B.L. Riggs, L.J. Melton III., R.A. Robb, J.J. Camp, E.J. Atkinson, JM. Peterson, P.A. Rouleau, C.H. McCollough, M.L. Bouxsein and S. Khosla (2004) Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J. Bone Miner. Res. 19 1945-1954.
95. B.L. Riggs, L.J. Melton, R.A. Robb, J.J. Camp, E.J. Atkinson, L. McDaniel, S. Amin, P.A. Rouleau and S. Khosla (2007) A population-based assessment of rates of bone loss at multiple skeletal sites: Evidence for substantial trabecular bone loss in young adult women and men. J. Bone Miner. Res. [Epub ahead of print]
96. V. Rochira, M. Faustini-Fustini, A. Balestrieri and C. Carani (2000) Estrogen replacement therapy in a man with congenital aromatase deficiency:effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. J. Clin. Endocrinol. Metab. 85 1841-1845.
97. V. Rochira, L. Zirilli, B. Madeo, C. Aranda, G. Caffagni, B. Fabre, V.E. Montangero, E.J.A. Roldan, L. Maffei and C. Carani (2007) Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidence of a priming effect of estrogen for sex steroids action on bone. Bone 40 1662-1668.
98. H. Sasano, M. Uzuki, T. Sawai, et al. (1997) Aromatase in human bone tissue. J. Bone Miner. Res. 12 1416-1423.
99. L.K. Saxon and C.H. Turner (2005) Estrogen receptor beta: The antimechanostat? Bone 36 185-192.
100. E. Schoenau, C.M. Neu, F. Rauch and F. Manz (2001) The development of bone strength at the proximal radius during childhood and adolescence. J. Clin. Endocrinol. Metab. 86 613-618.
101. E. Seeman (2001) Clinical review 137: Sexual dimorphism in skeletal size, density, and strength. J. Clin. Endocrinol. Metab. 86 4576-4584.
102. E. Seeman (2002) Pathogenesis of bone fragility in women and men. Lancet 359 1841-1850.
103. E. Seeman (2004) Estrogen, androgen, and the pathogenesis of bone fragility in women and men. Curr. Osteoporos. Rep. 2 90-96.
104. Shozu, M., Takayam, K., and Bulun, S. E. (1998). Mutation in 5’-flanking region of CYP19 gene causes excessive peripheral aromatase expression in boy with gynecomastia. In: “Proc. 80th Annu. Meet. Endoc. Soc., New Orleans, LA.”
105. M. Shozu, S. Sebastian, K. Takayama, et al. (2003) Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N. Engl. J. Med. 348 1855-1865.
106. N.A. Sims, S. Dupont, A. Krust, et al. (2002) Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone 30 18-25.
107. N.A. Sims, P. Clement-Lacroix, D. Minet, et al. (2003) A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice. J. Clin. Invest. 111 1319-1327.
108. F.A. Syed, U.I. Modder, D.G. Fraser, et al. (2005) Skeletal effects of estrogen are mediated by opposing actions of classical and nonclassical estrogen receptor pathways. J. Bone Miner. Res. 20 1992-2001.
109. E.R. Simpson, M.S. Mahendroo, G.D. Means, M.W. Kilgore, M.M. Hinshelwood, S. Graham-Lorence, B. Amarheh, Y. Ito, C.R. Fisher, M.D. Michael, C.R. Mendelson and S.E. Bulun (1994) Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr. Rev. 15 342-355.
110. E.R. Simpson, Y. Zhao, V.R. Agarwal, D.M. Dodson, S.E. Bulun, H.M. Hinshelwood, S. Graham-Lorence, T. Sun, C.R. Fisher, K. Qin and C.R. Mendelson (1997) Aromatase expression in health and disease. Recent Prog. Horm. Res. 52 185-214.
111. E. Simpson, M. Jones, S. Davis and G. Rubin (1999) Do intracrine mechanisms regulate aromatase expression? J. Steroid. Biochem. Mol. Biol. 69 447-452.
112. E. Simpson, G. Rubin, C. Clyne, et al. (2000) The role of local estrogen biosynthesis in males and females. Trends Endocrinol. Metab. 11 184-188.
113. E.V. Simpson and S.R. Davis (2001) Minireview: aromatase and the regulation of estrogen biosynthesis–some new perspectives. Endocrinology. 142 4589-4594.
114. C.W. Slemenda, C. Longcope, L. Zhou, S.L. Hui, M. Peacock and C.C. Johnston (1997) Sex steroids and bone mass in older men: Positive associations with serum estrogens and negative associations with androgens. J. Clin. Invest. 100 1755-1759.
115. E.P. Smith, J. Boyd, G.R. Frank, H. Takahashi, R.M. Cohen, B. Specker, R.C. Williams, D.B. Lubahn and K.S. Korach (1994) Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331 1056-1061.
116. M.R. Smith, M.A. Fallon, H. Lee and J.S. Finkelstein (2004) Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: A randomized controlled trial. J. Clin. Endocrinol. Metab. 89 3841-3846.
117. J.J. Stepan, M. Lachman, J. Zverina, V. Pacovsky and D.J. Baylink (1989) Castrated men exhibit bone loss. Effect of calcitonin treatment on biochemical indeces of bone remodeling. J. Clin. Endocrinol. Metab. 69 523-527.
118. C.A. Stratakis, A. Vottero, A. Brodie, et al. (1998) The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J. Clin. Endocrinol. Metab. 83 1348-1357.
119. M. Sundberg, P. Gärdsell, O. Johnell, E. Ornstein, Karlsson and I. Serbo (2003) Pubertal growth in the femoral neck is predominantly characterized by increased bone size and not by increased bone density: a 4-year longitudinal study. Osteoporos. Int. 14 548-558.
120. P. Szulc, B. Munoz, B. Claustrat, et al. (2001) Bioavailable estradiol may be an important determinant of osteoporosis in men. The MINOS Study. J. Clin. Endocrinol. Metab. 86 192-199.
121. P. Taxel and L.G. Raisz (1997) The effect of estrogen therapy on older men with low bone mass. J. Bone Miner. Res. 12(Suppl. 1), S353. [Abstract]
122. P. Taxel, D.G. Kennedy, P.M. Fall, A.K. Willard, J.M. Clive and L.G. Raisz (2001) The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. J. Clin. Endocrinol. Metab. 86 2869-2874.
123. K. Toda, T. Saibara, T. Okada, S. Onishi and Y. Shizuta (2001) A loss of aggressive behaviour and its reinstantement by oestrogen in mice lacking the aromatase gene (Cyp 19). J. Endocrinol. 168 217-220.
124. T.F. Tozum, M.E. Oppenlander, A.J. Koh-Paige, D.M. Robins and L.K. McCauley (2004) Effects of sex steroid receptor specificity in the regulation of skeletal metabolism. Calcif. Tissue Int. 75 60-70.
125. B. Uebelhart, F. Herrmann, I. Pavo, M.W. Draper and R. Rizzoli (2004) Raloxifene treatment is associated with increased serum estradiol and decreased bone remodeling in healthy middle-aged men with low sex hormone levels. J. Bone Miner. Res. 19 1518-1524.
126. P. Vandekerckhove, R. Lilford, A. Vail and E. Hughes (2000) Clomiphene or tamoxifen for idiopathic oligo/asthenospermia. Cochrane Database Syst. Rev. 2 CD000151
127. D. Vanderschueren, E. Van Herck, R. De Coster and R. Bouillon (1996) Aromatization of androgens is important for skeletal maintenance of aged male rats. Calcif. Tissue Int. 59 179-183.
128. D. Vanderschueren, E. van Herck, J. Nijs, A.G. Ederveen, R. De Coster and R. Bouillon (1997) Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology 138 2301-2307.
129. D. Vanderschueren, S. Boonen, A.G.H. Ederveen, et al. (2000) Skeletal effects of estrogen deficiency induced by an aromatase inhibitor in an aged male rat model. Bone. 27 611-617.
130. D. Vanderschueren, K. Venken, J. Ophoff, R. Bouillon and S. Boonen (2006) Clinical Review: Sex steroids and the periosteum—reconsidering the roles of androgens and estrogens in periosteal expansion. J. Clin. Endocrinol. Metab. 91 378-382.
131. K. Venken, K. De Gendt, S. Boonen, J. Ophoff, R. Bouillon, J.V. Swinnen, G. Verhoeven and D. Vanderschueren (2006) Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: A study in the androgen receptor knockout mouse model. J. Bone Miner. Res. 21 576-585.
132. O. Vidal, M.K. Lindberg, K. Hollberg, et al. (2000) Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc. Natl. Acad. Sci. USA 97 5474-5479.
133. R.D. Wasnich, P.D. Ross and J.W. Davis (1991) Osteoporosis: Current practice and future perspectives. Trends Endocrinol. Metab. 2 59-62.
134. S. Wickman, E. Kajantie and L. Dunkel (2003) Effects of suppression of estrogen action by the P450 aromatase inhibitor letrozole on bone mineral density and bone turnover in pubertal boys. J. Clin. Endocrinol. Metab. 88 3785-3793.
135. S.H. Windahl, O. Vidal, G. Andersson, J.A. Gustafsson and C. Ohlsson (1999) Increased cortical bone mineral content but unchanged trabecular bone mineral density in femal ER B−/− mice. J. Clin. Invest. 104 895-901.
136. S.H. Windahl, K. Hollberg, O. Vidal, J.A. Gustafsson, C. Ohlsson and G. Andersson (2001) Female estrogen receptor beta−/− mice are partially protected against age-related trabecular bone loss. J. Bone Miner. Res. 16 1388-1398.
137. M. Zachmann, A. Prader, E.H. Sobel, et al. (1986) Pubertal growth in patients with androgen insensitivity: Indirect evidence for the importance of estrogen in pubertal growth of girls. J. Pediat. (St. Louis) 108 694-697.